Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change ...

Epicrispr Biotechnologies, a clinical-stage company pioneering gene-modulating therapies, today announced that Amber Salzman, Ph.D., Chief Executive Officer, will present at the 44th Annual J.P.

In this week’s edition of InnovationRx, we look at the Forbes 30 Under 30 Healthcare list, the coming barriers to getting ...

Innovation cycles are shifting at a remarkable pace. Artificial intelligence, biotechnology and clean energy systems now influence how nations design public pol ...

Where HBS stands on today’s most hotly debated policy questions.As we began to wrap up the semester, we wanted to understand ...

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made a series of notable trades on Monday, December 1, according to ...

Advanced technologies in pharma manufacturing necessitate a redefinition of the Qualified Person's role, focusing on digital ...

Ryan, a leading global tax services and software provider, is pleased to announce it has been named one of the Best Places to Work in Pennsylvania, marking the 14th year the Firm has been honored for ...

On Jan. 23, hundreds of couples in Bangkok tied the knot in a mass wedding ceremony after a 2024 bill recognizing same-sex ...

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Tuesday. This is TheStreet’s Stock ...

At Korea Institute of Science and Technology (KIST), where research areas include materials, robotics and artificial intelligence, the team within its CJLab function were involved in Cas9 research.